• Science
    • Pipeline
    • Platform
  • Company
    • About
    • Team
  • News
  • Careers
  • Contact

Cartography Biosciences unearths cancer immunotherapy targets

by PantheonAdmin | Sep 22, 2022 | Media Coverage

On the Map: Cartography Charts a Course for Precision Cancer Treatments

by PantheonAdmin | Sep 6, 2022 | Media Coverage

Cartography Biosciences Launches to Accelerate Precision Immunotherapy with Comprehensive Antigen Profiling

by PantheonAdmin | Jul 19, 2022 | News

Why CAR T Therapies are Such a Headache with Kevin Parker

by PantheonAdmin | Feb 18, 2021 | Media Coverage

3 of 3 pages«

Recent Posts

  • Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors
  • Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs
  • Cartography Biosciences Expands Leadership Team with Appointment of Dan Rock, Ph.D., as Chief Scientific Officer to Advance Novel Oncology Programs into Clinic
  • Cartography Biosciences and Nested Therapeutics: Diamonds in the rough
  • Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts

Recent Comments

No comments to show.
  • Follow
  • Follow

Visit Us

230 E Grand Avenue, Suite 250
South San Francisco, CA 94080

Reach Out

hello@cartography.bio

Partnering

bd@cartography.bio

833-318-4749

Privacy Policy Terms & Conditions

© Cartography Biosciences, Inc.